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The authors wish to make the following correction to this paper [1].
Reference [8] refers to the wrong article. The correct reference [2] should be:
Abdulle, A.E.; Diercks, G.F.H.; Feelisch, M.; Mulder, D.J.; van Goor, H. The Role of Oxidative
Stress in the Development of Systemic Sclerosis Related Vasculopathy. Front. Physiol. 2018, 9, 1–15,
doi:10.3389/fphys.2018.01177.
The authors would like to apologize for any inconvenience caused to the readers by these changes.
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